What are the differences between a CBC (complete blood count), a BMP (basic metabolic panel), and a CMP (comprehensive metabolic panel), and when should each be ordered?

CBC vs CMP vs BMP: Key Differences and Clinical Indications

These three panels test fundamentally different body systems: CBC evaluates blood cells and hematologic function, BMP assesses basic kidney function and electrolytes, while CMP adds liver function and protein status to the BMP components.

What Each Panel Measures

Complete Blood Count (CBC)

• Hematologic components: White blood cells (WBC), red blood cells (RBC), hemoglobin, hematocrit, platelets, and their characteristics (MCV, RDW, MPV)
• Primary purpose: Detect anemia, infection, bleeding disorders, hematologic malignancies, and inflammatory states 1

Basic Metabolic Panel (BMP)

• 8 tests: Sodium, potassium, chloride, carbon dioxide (bicarbonate), glucose, blood urea nitrogen (BUN), creatinine, and calculated GFR
• Primary purpose: Assess kidney function, electrolyte balance, acid-base status, and glucose control

Comprehensive Metabolic Panel (CMP)

• 14 tests: All BMP components PLUS liver function tests (ALT, AST, alkaline phosphatase, total bilirubin) and proteins (albumin, total protein), plus calcium
• Primary purpose: Everything the BMP does plus liver function assessment and nutritional/protein status

When to Order Each Panel

CBC Indications

Order CBC when evaluating for hematologic, infectious, or inflammatory conditions 2:

• Suspected anemia or bleeding (history of blood loss, fatigue, pallor)
• Suspected infection (fever, leukocytosis concerns)
• Preoperative assessment in specific populations 2:
  • Patients with liver disease, history of anemia/bleeding, or hematologic disorders
  • Cardiovascular surgery (any age)
  • Neurosurgery patients >60 years
  • Major surgery (grade 3-4) in ASA class 2-3 patients with cardiovascular or respiratory disease
  • Any surgery in ASA class 3 patients with renal disease
• Monitoring known hematologic conditions or chemotherapy

Avoid routine daily CBCs in stable hospitalized patients—this represents unnecessary testing that increases costs without improving outcomes 3

BMP Indications

Order BMP when assessing kidney function, electrolyte disturbances, or metabolic derangements:

• Acute kidney injury or chronic kidney disease monitoring
• Electrolyte disturbances: Suspected hypo/hyperkalemia, hypo/hypernatremia, acid-base disorders
• Diabetes management: Glucose monitoring in acute settings
• Medication monitoring: Diuretics, ACE inhibitors, lithium, digoxin
• Dehydration or volume status assessment
• Preoperative assessment 2:
  • ASA class 3 patients with renal disease undergoing any surgery
  • ASA class 2 patients with renal disease undergoing major surgery (grade 3-4)
  • Patients >60 years with respiratory disease undergoing high-intermediate risk surgery

Cost consideration: BMP costs approximately $21 less than CMP 4. In patients without liver disease risk factors, BMP is sufficient and avoids unnecessary testing 5, 6

CMP Indications

Order CMP when liver function assessment is needed in addition to metabolic/renal evaluation 7:

• Suspected liver disease: Right upper quadrant pain, jaundice, hepatomegaly, ascites 4
• Known liver disease: Chronic liver disease, cirrhosis, hepatitis monitoring
• Risk factors for liver disease:
  • Alcohol use disorder
  • Obesity/metabolic syndrome
  • Medication hepatotoxicity concerns
  • History of viral hepatitis
• Malnutrition assessment: Albumin and total protein provide nutritional status
• Comprehensive metabolic assessment when both liver and kidney function need evaluation

Critical Pitfalls to Avoid

Don't Order CMP Reflexively

The inclusion of calcium in CMP has led to a 3-fold increase in calcium testing without changing diagnosis rates of calcium disorders (1.29% before vs 1.27% after implementation) 5. Many CMP components go unused in patients without specific indications.

Recognize Test Limitations

• Calcium in CMP: Often unnecessary; consider ordering separately only when indicated 5
• Creatinine in capillary samples: Shows consistent negative bias compared to venous samples 8
• Normal liver enzymes don't exclude cirrhosis: AST and ALT can be normal even with advanced fibrosis 7
• Preanalytical variables: IV fluid contamination, hemolysis, and collection technique significantly affect results 9

Target Testing Based on Clinical Variables

In pediatric emergency settings, patients with none of these 12 variables had normal CMP results: right upper quadrant pain, overdose, emesis, liver disorder, malignancy, heart disease, bleeding disorder, jaundice, right upper quadrant tenderness, hepatomegaly, ascites/edema, or shock. Using BMP instead in these low-risk patients could save $7,125 annually per emergency department 4.

High-Risk Populations Requiring Closer Monitoring

• Diabetes: 23-fold increased odds of abnormal glucose requiring intervention 6
• Chronic kidney disease: 3-fold increased odds of abnormal creatinine and 1.8-fold increased odds of abnormal potassium 6
• Abnormal preoperative values: Strongly predict need for postoperative intervention across all electrolytes 6

Practical Algorithm

1. Start with clinical question: What system am I evaluating?

   • Blood/hematologic → CBC
   • Kidney/electrolytes/glucose → BMP
   • Liver + kidney/metabolic → CMP

2. Consider comorbidities:

   • Diabetes or CKD → More likely to need intervention based on metabolic panels 6
   • Liver disease history → CMP warranted 7
   • No major comorbidities + normal baseline → BMP sufficient

3. Avoid reflexive daily ordering: Only repeat when clinical status changes or results will alter management 3

4. Use targeted testing: If only concerned about specific electrolytes or liver enzymes, order individual tests rather than entire panels when appropriate